CHRU de Tours- Hôpital Trousseau

The medical center is at the forefront of rheumatology research, focusing on innovative treatments for rheumatoid arthritis. The center's research aims to enhance the efficacy of therapies for patients who have shown inadequate responses to previous treatments.

• Comparative studies of biologic agents
• Subcutaneous administration techniques
• Targeted treatment strategies

By conducting trials such as the comparison between tocilizumab and abatacept, the center contributes significantly to the development of superior therapeutic options for managing rheumatoid arthritis.